Free Trial

Xometry (NASDAQ:XMTR) Director Sells 1,800 Shares of Stock

Xometry logo with Industrials background
Image from MarketBeat Media, LLC.

Key Points

  • Director Fabio Rosati sold 1,800 Xometry shares at an average price of $120.52, totaling $216,936. He retained 89,867 shares after the sale.
  • Xometry beat quarterly earnings and revenue expectations, reporting EPS of $0.28 versus $0.19 expected and revenue of $252.44 million, up 39.5% year over year.
  • Analysts rate the stock a consensus “Moderate Buy”, with an average price target of $123.64; recent targets include $135 from Citizens JMP and $140 from JPMorgan.
  • MarketBeat previews top five stocks to own in December.

Xometry, Inc. (NASDAQ:XMTR - Get Free Report) Director Fabio Rosati sold 1,800 shares of Xometry stock in a transaction that occurred on Monday, November 9th. The shares were sold at an average price of $120.52, for a total transaction of $216,936.00. Following the sale, the director owned 89,867 shares in the company, valued at approximately $10,830,770.84. The trade was a 1.96% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.

Xometry Price Performance

XMTR traded down $1.28 during trading on Tuesday, hitting $119.31. 1,538,371 shares of the company traded hands, compared to its average volume of 887,125. The company has a market cap of $6.18 billion, a PE ratio of -350.90 and a beta of 1.33. Xometry, Inc. has a 1 year low of $35.86 and a 1 year high of $123.39. The company has a current ratio of 3.15, a quick ratio of 3.20 and a debt-to-equity ratio of 0.40. The stock's 50-day simple moving average is $98.74 and its two-hundred day simple moving average is $77.52.

Xometry (NASDAQ:XMTR - Get Free Report) last issued its earnings results on Tuesday, November 3rd. The company reported $0.28 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.19 by $0.09. The firm had revenue of $252.44 million for the quarter, compared to analysts' expectations of $235.54 million. Xometry had a positive return on equity of 0.18% and a negative net margin of 1.97%. The business's revenue was up 39.5% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.11 earnings per share. As a group, sell-side analysts anticipate that Xometry, Inc. will post 0.03 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Xometry

Several institutional investors have recently modified their holdings of XMTR. Odyssean LLC purchased a new position in Xometry during the second quarter worth $1,464,000. Zevenbergen Capital Investments LLC increased its position in Xometry by 115.1% during the third quarter. Zevenbergen Capital Investments LLC now owns 297,552 shares of the company's stock valued at $30,603,000 after acquiring an additional 159,227 shares during the last quarter. Quantinno Capital Management LP grew its holdings in Xometry by 759.5% during the 1st quarter. Quantinno Capital Management LP now owns 32,694 shares of the company's stock valued at $1,335,000 after purchasing an additional 28,890 shares during the last quarter. Sylebra Capital LLC grew its holdings in Xometry by 31.3% during the 1st quarter. Sylebra Capital LLC now owns 535,624 shares of the company's stock valued at $21,875,000 after purchasing an additional 127,637 shares during the last quarter. Finally, Empowered Funds LLC purchased a new stake in Xometry in the 1st quarter worth about $1,150,000. 97.31% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

A number of research firms have issued reports on XMTR. UBS Group lifted their price objective on Xometry from $95.00 to $108.00 and gave the stock a "neutral" rating in a research note on Wednesday, November 4th. Zacks Research upgraded Xometry from a "hold" rating to a "strong-buy" rating in a research report on Friday. Citizens Jmp increased their target price on Xometry from $120.00 to $135.00 and gave the company a "market outperform" rating in a research report on Wednesday, November 4th. Raymond James Financial set a $120.00 target price on shares of Xometry in a report on Tuesday, September 22nd. Finally, JPMorgan Chase & Co. boosted their price target on shares of Xometry from $120.00 to $140.00 and gave the stock an "overweight" rating in a research report on Wednesday, November 4th. One research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, three have assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, Xometry currently has a consensus rating of "Moderate Buy" and an average target price of $123.64.

View Our Latest Research Report on Xometry

Xometry Company Profile

(Get Free Report)

Xometry, Inc. operates a digital marketplace that connects businesses needing custom-manufactured parts with a network of manufacturing suppliers. Its platform uses automated quoting and matching tools to help customers source parts and production services. Services available through the marketplace include CNC machining, 3D printing, sheet metal fabrication, injection molding, and other manufacturing processes. Xometry also offers related services such as product sourcing and procurement tools, and operates Thomasnet, an online platform for discovering and evaluating industrial suppliers.

Read More

Insider Buying and Selling by Quarter for Xometry (NASDAQ:XMTR)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Xometry Right Now?

Before you consider Xometry, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Xometry wasn't on the list.

While Xometry currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 7 Best High-Yield Dividend Stocks for 2027 Cover

Looking for higher dividend income in 2027? Discover seven high-yield dividend stocks with attractive payouts, proven dividend histories and growth potential.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines